Holders over time
- HAFN
- TMO
| Quarter | HAFN | TMO |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 29 holders, $38.9bn |
| Q4 2020 | none listed holders, n.a. | 33 holders, $39.2bn |
| Q1 2021 | none listed holders, n.a. | 35 holders, $36.5bn |
| Q2 2021 | none listed holders, n.a. | 33 holders, $38.3bn |
| Q3 2021 | none listed holders, n.a. | 32 holders, $42.6bn |
| Q4 2021 | none listed holders, n.a. | 38 holders, $50.1bn |
| Q1 2022 | none listed holders, n.a. | 32 holders, $43.2bn |
| Q2 2022 | none listed holders, n.a. | 33 holders, $38.9bn |
| Q3 2022 | none listed holders, n.a. | 26 holders, $34.3bn |
| Q4 2022 | none listed holders, n.a. | 29 holders, $37.0bn |
| Q1 2023 | none listed holders, n.a. | 35 holders, $37.1bn |
| Q2 2023 | none listed holders, n.a. | 39 holders, $33.5bn |
| Q3 2023 | none listed holders, n.a. | 39 holders, $32.6bn |
| Q4 2023 | none listed holders, n.a. | 41 holders, $32.7bn |
| Q1 2024 | none listed holders, n.a. | 30 holders, $34.1bn |
| Q2 2024 | none listed holders, n.a. | 38 holders, $30.6bn |
| Q3 2024 | none listed holders, n.a. | 30 holders, $33.8bn |
| Q4 2024 | 3 holders, $157m | 36 holders, $27.6bn |
| Q1 2025 | 3 holders, $113m | 31 holders, $24.2bn |
| Q2 2025 | 3 holders, $125m | 39 holders, $18.8bn |
| Q3 2025 | 4 holders, $146m | 32 holders, $21.9bn |
| Q4 2025 | 3 holders, $125m | 32 holders, $29.9bn |
| Q1 2026 | 3 holders, $145m | 34 holders, $24.4bn |
| Q2 2026 | 3 holders, $123m | 36 holders, $26.4bn |
- Holders
- 3
- Reported value
- $157m
- Buyers
- 3
- Sellers
- 0
Not ranked this quarter: its new positions are allocations in a new listing.
Thermo Fisher Scientific Inc
- Holders
- 36
- Reported value
- $27.6bn
- Buyers
- 22
- Sellers
- 15
Breadth +7 among 94 comparable managers.
Who holds both, Q4 2024
Only HAFN (1)
Only TMO (34)
AllianceBernstein LP, AQR Capital Management LLC, Baillie Gifford & Co, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Farallon Capital Management LLC, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Polen Capital Management LLC, Quantbot Technologies LP, Renaissance Technologies LLC, and 9 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.